Virtual reality tumor navigated robotic radical prostatectomy by using three-dimensional reconstructed multiparametric prostate MRI and
3D reconstruction
augmented reality
radical prostatectomy
robotic
training
virtual reality
Journal
BJUI compass
ISSN: 2688-4526
Titre abrégé: BJUI Compass
Pays: United States
ID NLM: 101764975
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
16
03
2020
revised:
04
04
2020
accepted:
15
04
2020
entrez:
27
4
2022
pubmed:
9
5
2020
medline:
9
5
2020
Statut:
epublish
Résumé
To evaluate the use and benefits of tumor navigation during performing robotic assisted radical prostatectomy (RARP). Borders of the visible tumor(s) was/were and surrounding structures marked on multiparametric prostate magnetic resonance imaging (mpMRI) and Mean patient age was 60.6 ± 3.7 years (range, 56-66). All VR models were finalized with the agreement of radiologist, urologist, nuclear physician, and engineer. Surgeon examined images before the surgery. All VR models were found very useful particularly in pT3 diseases. Pathological stages included pT2N0 (n = 1), pT3aN0 (n = 1), pT3aN1 (n = 2), and pT3bN1 (n = 1). Positive surgical margins (SMs) occurred in two patients with extensive disease (pT3aN1 and pT3bN1) and tumor occupied 30% and 50% of the prostate volumes. Mean estimated blood loss was 150 ± 86.6 cc (range, 100-300). Mean follow-up was 3.4 ± 1.7 months (range, 2-6). No complication occurred during perioperative (0-30 days) and postoperative (30-90 days) periods in any patient. 3D reconstructed VR models by using mpMRI and Ga68 PSMA-PET/CT images can be accurately prepared and effectively applied during RARP that might be a useful tool for tumor navigation. Images show prostate tumors and anatomy and might be a guide for the console surgeon. This is promising new technology that needs further study and validation.
Identifiants
pubmed: 35474863
doi: 10.1002/bco2.16
pii: BCO216
pmc: PMC8988524
doi:
Types de publication
Journal Article
Langues
eng
Pagination
108-115Informations de copyright
© 2020 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.
Références
J Endourol. 2014 Jun;28(6):625-30
pubmed: 24450285
Abdom Radiol (NY). 2020 Oct;45(10):3293-3300
pubmed: 32002569
BJU Int. 2013 Jun;111(7):1081-90
pubmed: 23379850
N Engl J Med. 2020 Mar 5;382(10):917-928
pubmed: 32130814
Eur Urol Focus. 2020 Mar 15;6(2):218-220
pubmed: 31113757
Int J Comput Assist Radiol Surg. 2019 Apr;14(4):723-732
pubmed: 30680601
BJU Int. 2010 Jan;105(1):21-7
pubmed: 19549118
J Nucl Med. 2018 Feb;59(2):204-209
pubmed: 28747519
Int J Med Robot. 2015 Mar;11(1):8-14
pubmed: 24898193
Eur Urol. 2014 Jul;66(1):138-44
pubmed: 24411279
BJU Int. 2019 May;123(5):834-845
pubmed: 30246936
Turk J Urol. 2019 Sep 1;45(5):357-365
pubmed: 31509508
Cureus. 2018 Jan 2;10(1):e2018
pubmed: 29531871
World J Urol. 2018 Feb;36(2):201-207
pubmed: 29127451
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Eur Urol. 2012 Apr;61(4):679-85
pubmed: 22206800
World J Surg Oncol. 2020 Feb 24;18(1):42
pubmed: 32093688
Minerva Chir. 2013 Oct;68(5):499-512
pubmed: 24101007
Urology. 2018 May;115:184
pubmed: 29548868
BJUI Compass. 2020 May 09;1(3):108-115
pubmed: 35474863
Eur Urol. 2016 Feb;69(2):377-9
pubmed: 26431913